Key Takeaways
- Sharp recovery from a deep trough: Standalone revenue rose 26% YoY to ~INR 500 crores, EBITDA swung from INR 10 crores to INR 65 crores, and PAT turned positive at INR 34 crores, driven by better product mix and plant utilization.
- Agrochemical demand is back, pricing is not: Global destocking that crushed exports for two years is over, and demand is improving, but raw material and sales prices remain at bottom levels, capping margin upside.
- TiO2 gets a policy lifeline: An antidumping duty of $460–$681/MT on Chinese imports was imposed May 10, 2025, but the real P&L impact won't arrive until Q3 FY26 after channel inventory clears.
- The MPP plant is the growth bet, but the INR 1,000 crore target is now soft: Management declined to confirm the FY27 revenue goal, saying 75–80% utilization is still 2–3 years away.
- What to watch next quarter: Whether TiO2 realizations actually improve once the antidumping duty bites, the pace of new product registrations in Crop Protection, and any sign that agrochemical pricing has bottomed.
The Turnaround: What Drove Q4
- Crop Protection led the charge: Production up 14% YoY to ~42,000 MT at 76% utilization; revenue up 34% YoY to ~INR 1,450 crores; EBITDA surged 301% YoY to ~INR 177 crores. The two-year global inventory overhang that crushed Meghmani's export-heavy business has finally cleared.
- Pigments swung back to black: Production up 11% YoY to ~15,000 MT at 46% utilization; revenue up 20% YoY to INR 553 crores; EBITDA turned positive at ~27% from a loss of INR 6.6 crores a year ago. The segment still posted a full-year loss of INR 55 crores, dragged down by TiO2.
- Crop Nutrition hit self-sufficiency: A critical milestone achieved in FY25, with one-time better realizations in select markets delivering ~INR 20 crores in incremental PBIT this quarter, a benefit management flagged as not sustainable.
- Full-year picture confirms the swing: FY25 revenue grew 30% YoY to ~INR 2,000 crores; EBITDA rose to INR 180 crores from INR 9.5 crores; PAT turned around to INR 66 crores from a loss of INR 57 crores.
Patel: "It will definitely help to improve the bottom line, because at the current pricing level, it was very difficult to run the plant and to recover the cost."
TiO2: The Antidumping Wildcard
- The problem: TiO2 prices have been under intense pressure from aggressive Chinese dumping, making it difficult to recover costs at current realizations. The plant is high-CAPEX and high-maintenance, so utilization is the key cost lever.
- The fix: The Ministry of Finance imposed an antidumping duty of $460 to $681 per metric ton on Chinese TiO2 imports on May 10, 2025. Similar duties already exist in Europe and Brazil, and the US has extra tariffs on Chinese goods, giving Indian players a structural advantage.
- The lag: Management expects the real impact only from Q3 FY26 onward, because the channel is still holding inventory bought before the duty. The next 2–3 months will be an absorption period.
- The strategy: Current focus is on the first phase of 16,500 tonnes. Once better utilization is achieved, small modifications can increase capacity with no major CAPEX. Management declined to give a timeline for doubling to 33,000 tonnes.
- Export push: Sampling and product approval are ongoing in export markets. With duties now in place across major geographies, management is exploring different strategies to sell at better prices and doesn't want to miss any opportunity.
Patel: "Whatever gives the better profitability, we will be focusing."
Agrochemicals: Demand Returns, Margins Wait
- The destocking is done: Heavy global inventory that took almost two years to clear is now gone. No major inventory remains in key markets, and good demand is coming back. Raw material and sales prices are both stable at bottom levels, with no improvement yet.
- Pricing is the ceiling: Management believes pricing has hit the floor, so any demand improvement should bring a little pricing improvement. But China still has heavy production capacity, which will cap how far prices can rise.
- New products are the growth engine: Over the next two years, the majority of growth will come from recently introduced products like Flubendamide, Cyfluthrin, beta-Cyfluthrin, Flonicamid, Ethiprole, and Spiromesifen. Registrations are ongoing in different markets. Margins are under pressure but new products carry better realizations.
- 2,4-D has a US advantage: A very high antidumping duty on Chinese 2,4-D in the US gives Indian players like Meghmani and Atul an edge. Meghmani has a strong US presence, though 2,4-D is only 15–20% of agrochemical revenue, not the 70% one analyst assumed.
- Pyrethroid risk is contained: China imposed an antidumping duty on Cypermethrin from India, where Meghmani is the second-lowest-cost producer. But Meghmani's China revenue is very small, and other Indian players cannot easily enter export markets because agrochemicals require registrations.
Pigments: A Tale of Two Businesses
- CPC Blue is a diminished asset: Prices have dropped 40–45% from the 2022 peak. Management is explicit that the 2021–22 pricing was unrealistic and will not return. Some improvement is expected, but not to those levels.
- Conventional pigments are in structural decline: Oversupply from small, unconventional players makes it impossible for a large, compliant player like Meghmani to compete on cost. Management is not investing anything in the conventional pigment business and is running it at an optimum level only.
- The margin reset is permanent: The Pigment green and blue business used to deliver 13–15% EBITDA margins pre-COVID. But in the last 3–4 years, competitors added significant capacity during the good years, and the market didn't grow, creating permanent pricing pressure. Management now targets only 8–9% EBITDA margin for FY26.
Patel: "People don't have capability of thinking, and whether the market is growing or not. Because once they see the profitability 13%, 14%, 15%, they want to increase the capacity. But the market is not growing, and that led to very high production capacity, which ultimately created a pressure on the pricing."
The MPP Plant: Growth Anchor, Timeline Slipping
- The ambition: The multipurpose plant is the primary growth vehicle, designed to house the new product pipeline. At 90% utilization, it can generate INR 1,000 crores in revenue.
- The reality check: Management declined to confirm the FY27 target, calling it "difficult to mention at this level." Utilization is expected to reach 75–80% only over the next 2–3 years, with optimum 90% pushed to FY27/FY28.
- No EBIT loss at current scale: At INR 250 crores in revenue, the MPP plant has not posted an EBIT loss, correcting an analyst's assumption.
- Phase 2 CAPEX is not imminent: No significant CAPEX is required for the second phase right now. Management will announce the number once first-phase utilization is achieved.
Crop Nutrition & Nano Urea: Early Innings
- Self-sufficiency achieved: Meghmani Crop Nutrition reached self-sufficiency in FY25, a critical milestone. The segment delivered ~INR 20 crores in PBIT this quarter on ~INR 40–44 crores revenue, but that profitability was a one-time opportunity from better realizations in select markets.
- Nano Urea is a long game: Management is bullish on exports and is working in 35–40 countries from a development standpoint. Trial orders were received in FY25. But capacity utilization above 50% will take another 2–3 years, and no production targets have been set, only sales targets.
- Farmer adoption needs hand-holding: Feedback from farmers who use the product without proper guidance is not positive, so the company is investing in field demonstrations to show how and when to apply it.
- Margin commitment: Management targets a 20% EBITDA margin for the Crop Nutrition segment, driven more by development activity and sales than by plant utilization.
Patel: "Slowly gradually as there will be success in the numbers over a period of next 2 to 3 years, we see significant growth taking place in this segment also."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 15–20% overall revenue growth | FY26 |
| Crop Protection EBITDA margin | 15–16% | FY26 |
| Pigment (green & blue) EBITDA margin | 8–9% | FY26 |
| Crop Nutrition EBITDA margin | 20% | FY26 |
| Consolidated EBITDA margin | Remain in double digits | FY26 |
| TiO2 realizations | Improvement begins after channel inventory clears | Mid-Q2 to early Q3 FY26 |
| Standalone debt-free | Long-term debt ~INR 442 crores; ~INR 160 crores repayment planned | FY26–FY27 |
| MPP plant utilization | 75–80% | Next 2–3 years |
| Nano Urea utilization | Above 50% | Next 2–3 years |
| Brazil subsidiary | Final RBI approval awaited; implementation to follow | Any time |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Standalone revenue | ~₹500 cr, +26% YoY |
| Standalone EBITDA | ~₹65 cr, vs ₹10 cr in Q4 FY24 |
| Standalone PAT | ₹34 cr, vs loss of ₹0.4 cr in Q4 FY24 |
| Consolidated EBITDA margin | 12% |
| FY25 revenue | ~₹2,000 cr, +30% YoY |
| FY25 PAT | ₹66 cr, vs loss of ₹57 cr in FY24 |
| FY25 EBITDA | ₹180 cr, vs ₹9.5 cr in FY24 |
| FY26 revenue growth guidance | 15% to 20% |
| Crop Protection segment FY25 revenue | ~₹1,450 cr, +34% YoY |
| Crop Protection segment FY25 EBITDA | ~₹177 cr, +301% YoY |
| Crop Protection segment FY25 capacity utilization | ~76% |
| Crop Protection segment FY26 EBITDA margin guidance | 15% to 16% |
| Pigment segment FY25 revenue | ₹553 cr, +20% YoY |
| Pigment segment FY25 EBITDA | ~27% (positive), vs negative ₹6.6 cr in FY24 |
| Pigment segment FY25 capacity utilization | ~46% |
| Conventional Pigment (Green & Blue) FY25 EBITDA | ~₹27 cr |
| Conventional Pigment business FY26 EBITDA margin guidance | 8% to 9% |
| TiO2 antidumping duty imposed | $460 to $681 per metric ton, effective May 10, 2025 |
| TiO2 quarterly EBIT loss | ~₹25–26 cr |
| MPP plant FY25 revenue | ~₹250 cr |
| MPP plant current utilization | ~45% |
| Crop Nutrition (MCNL) segment Q4 revenue | ~₹40–44 cr |
| Crop Nutrition (MCNL) segment Q4 PBIT | ~₹20 cr |
| Crop Nutrition (MCNL) long-term EBITDA margin target | ~20% |
| Long-term debt (as of Mar 31, 2025) | ~₹442 cr |
| Planned debt repayment in FY26 | ~₹160 cr |
| Renewable energy cost per unit | ₹4–5, vs ₹9–9.5 from grid |
| CPC Blue price decline vs 2022 peak | 40% to 45% lower on average |
| Agrochemical volume growth FY25 | 14% YoY |
| Agrochemical volume growth Q4 FY25 | ~8% lower YoY |
| Brazil market expected annual growth | 15% to 20% |